Moximed
Signal active
Organization
Contact Information
Overview
Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
About
Industries
Biotechnology, Health Care, Medical Device
Founded
2006
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Moximed headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $20.5B in funding across 96 round(s). With a team of 11-50 employees, Moximed is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Moximed, raised $45.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
0
Lead Investors
0
Total Funding Amount
$244.2M
Details
6
Moximed has raised a total of $244.2M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2007 | Seed | |||
| 2016 | Early Stage Venture | 12.6M | ||
| 2015 | Early Stage Venture | 33.0M | ||
| 2011 | Early Stage Venture | 45.8M |
Investors
Moximed is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Moximed | - | FUNDING ROUND - Moximed | 12.6M |
| GBS Ventures | - | FUNDING ROUND - GBS Ventures | 12.6M |
| Moximed | - | FUNDING ROUND - Moximed | 33.0M |
| Vertex Ventures | - | FUNDING ROUND - Vertex Ventures | 33.0M |
Recent Activity
There is no recent news or activity for this profile.